Comparative Study on Medical Artificial Intelligence Algorithm Assisted and Conventional Imaging Examination Methods

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorShanghai Jiao Tong University Affiliated Sixth People's Hospital

About this trial

Chest wall tumors are one of the important diseases in thoracic surgery, and surgery remains the main method for treating this disease in clinical practice. The surgery for chest wall tumors requires extensive resection, and more importantly, precise resection. If the resection range is insufficient, it is easy to cause tumor recurrence and metastasis, which affects the patient's survival; If the resection range is too large, it will cause damage to the chest wall structure, affecting the patient's postoperative recovery and quality of life. At present, the determination of the surgical resection range mainly relies on the experience of the surgeon and the results of imaging examinations. Even if experienced surgeons still have multiple imaging examination results, there are still clinical difficulties of insufficient or excessive resection. Medical artificial intelligence is the in-depth application of artificial intelligence technology in the field of medicine. By processing and analyzing massive amounts of medical data, it can accurately locate tumors and optimize surgical plans. Therefore, it is proposed to compare the clinical effects of surgical resection of chest wall tumors using medical artificial intelligence algorithms and conventional imaging examination methods, in order to understand whether it can achieve more accurate tumor resection.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Patients with benign or malignant chest wall tumors require surgical treatment ,meanwhile they have good overall condition and no signs of metastasis,

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

100 Participants
are grouped into 2 trial groups
Group A: Medical Artificial Intelligence Algorithm Assistance Group
Group B: Routine imaging examination group

Trial outcomes

Primary outcomes

1

Pathological results of surgical margins for chest wall tumors

Pathological diagnosis of residual tissue cells after tumor resection

Time frame
3 years

Secondary outcomes

1

Surgical margins planned by medical artificial intelligence

Surgical resection edges and ranges delineated with the assistance of medical artificial intelligence algorithms

Time frame
3 years
2

Surgical margins planned using conventional imaging techniques

The surgical resection edge and range delineated by conventional imaging examination methods

Time frame
3 years
3

recurrence-free survival, RFS

The time from surgery to the earliest evidence of recurrence

Time frame
3 years
4

Disease-free survival,DFS

The time at which the patient dies due to disease recurrence or progression after surgery

Time frame
3 years

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: